ADAR POONAWALLA
Serum Institute Of India Ships Millions Of Covishield Vaccine Doses Across The Country Ahead Of ‘Biggest Vaccination Drive’
Covishield To Be Sold at Rs 1,000 in Private Markets, Special Price of Rs 200 Given Only to GoI for First 100 Mn Doses, Says Adar Poonawalla
COVID-19 Vaccine: Serum Institute Of India and Bharat Biotech Issue Joint Statement, Adar Poonawalla Says 'This Should Clarify Any Miscommunication'
Oxford-AstraZeneca COVID-19 Vaccine to Cost Rs 219-292 to Government; Rs 438-584 in Private Market: Serum Institute of India
COVID-19 Vaccine Covishield Will Be Sold at Rs 1,000 Per Dose in Market if Government Allows, Says Adar Poonawalla
COVID-19 Vaccine: Adar Poonawalla Says SII Ready With Stockpile of 40–50 Million Covishield Doses
Serum Institute to Produce 300 Million Doses of AstraZeneca-Oxford's COVID-19 Vaccine by July 2021, Says CEO Adar Poonawalla
Adar Poonawalla Says Government Should Protect Vaccine Manufacturers From Lawsuits in Case of Adverse Reactions
Oxford COVID-19 Vaccine: SII Responds To Chennai Man's Rs 5 Crore Compensation Notice, Says No Relation Of Medical Condition With Vaccine Trial
Adar Poonawalla Praises Narendra Modi, Says ‘Amazed at How Much Prime Minister Knew About Vaccine’
Covishield Vaccine: Emergency Use Authorisation Request in Two Weeks, Govt Likely to Buy 300-400 Million Doses by July, Says Adar Poonawalla
Oxford COVID-19 Vaccine ‘70% Effective’, Serum Institute Chief Adar Poonawalla Says India Could Give Nod By Year-End
Oxford COVID-19 Vaccine Should be Available for Public by April 2021, Maximum Price Rs 1,000: Seram Institute CEO Adar Poonawalla
COVID-19 Vaccine Covishield May Get Emergency Use Authorisation From India in December 2020, Says Report
When Will COVID-19 Vaccine Covishield, Developed by Oxford-AstraZeneca, Be Available? Adar Poonawalla Responds
Google Trends